TED Member States· European UniontenderOpen · 05 Nov 2026
Vedolizumab II.
Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha
Deadline 05 Nov 2026Deadline05 Nov 2026
Estimated valueCZK 35,615,320
CPV category33652300
Published25 Sep 2026
Reference666083-2026
Notice summary
The subject of this public contract is the ongoing supply of the medicinal product containing the active substance Vedolizumab for the needs of the Central Military Hospital - Military Faculty Hospital Prague in accordance with the procurement conditions.
Is this worth bidding on?
Tender Radar scores every tender against your company profile, surfaces the matching services, and flags the ones worth your time — across Europe and beyond. Sign in to see the relevance match and full AI analysis for this opportunity.